Navigation Links
Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
Date:10/31/2012

EAST RUTHERFORD, N.J., Oct. 31, 2012 /PRNewswire/ --  Due to complications from the storm affecting the East Coast, Cambrex Corporation (NYSE: CBM, "Cambrex") will now report its results of the third quarter ended September 30, 2012 after the market closes Monday, November 5, 2012

The Company will also host a conference call to discuss the financial results Monday, November 5, 2012 at 4:45 p.m. EST.

 Third Quarter 2012 Earnings Conference Call When:  

Monday, November 5, 2012 at 4:45 p.m. Eastern Time Dial-in:  

1-888-430-8705 for U.S.1-719-325-2455 for International Passcode:  1704787Dial-in Replay:

1-888-203-1112 for U.S.1-719-457-0820 for InternationalPasscode:  1704787Available through Monday, November 12, 2012Webcast:www.cambrex.comAbout CambrexCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.


'/>"/>
SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cambrex Reports Second Quarter 2012 Results
2. Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
3. Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to Thursday, November 1, 2012 Due To Expected Severe Weather Conditions
4. InterMune To Release Third Quarter Financial Results On November 7
5. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
6. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
7. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
8. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
9. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
10. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
11. Origin Agritech Limited to Announce FY2012 Third Quarter Financial Results on August 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... presentation to investors on Tuesday, July 29, 2014, ... presentation will include an overview of Asterias, business ... webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... Research and Markets has announced ... Analytical Instruments Market 2014-2018" report to their offering. ... Genomics is the study of the gene and its ... and functions of proteomes or sets of proteins by ... involves the mapping of genes and DNA sequencing to ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... Potential Future Application of Stem Cells as a ... Treatment for Diabetes ... Nature Biotechnology, SAN DIEGO, Feb. 20 Novocell, Inc., a stem cell,engineering ... cells can be turned into pancreatic cells,capable of producing insulin in mice. The ...
... PPD, Inc. (Nasdaq:,PPDI) today announced its plans to begin ... common stock may be purchased from time to time,in the ... a share repurchase program in,view of the current price at ... balance sheet and its ability to generate cash,as well as ...
... Rotarix Would be the Only Vaccine Indicated to Prevent, ... Circulating Types, Offering, Completion of the Vaccination by ... GAITHERSBURG, Md. and PHILADELPHIA, Feb. 20 ,GlaxoSmithKline (NYSE: ... Drug,Administration,s (FDA) Vaccines and Related Biological Products Advisory,Committee (VRBPAC) ...
Cached Biology Technology:Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 2Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3PPD Announces Plan to Repurchase Shares of its Common Stock 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 3GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 4
(Date:7/25/2014)... scientists from 25 countries and 35 states will ... the Genetics Society of America (GSA) next week ... conference will feature close to 500 presentations (including ... including gene expression and regulation, functional genomics, chemical ... and a variety of diseases. , Of ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
(Date:7/25/2014)... KANSAS CITY, MOResearchers at the Stowers Institute for ... classes of pheromone receptors, and found pheromones crucial to ... one class of receptors helps a male mouse detect ... other class of receptors lets him know if the ... sets of pheromones are critical to trigger mating. Stowers, ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2It takes two to court 2It takes two to court 3
... loss of dopamine neurons is a hallmark of many ... Stem cell biology and regenerative medicine offer novel therapies ... the online open-access journal PLoS Biology Dr. Raja Kittappa, ... McKay show that the transcription factor FOXA2 plays a ...
... invasive plant species is complex, to say the least. ... create conditions that promote population explosions of invasive plants, ... to the ecosystems they inhabit. On the other, fire ... growth. A new general technical report published by ...
... New microscopic pictures show the first-ever physical evidence ... (CF) disease. Researchers at the University of Alabama ... protein called epithelial sodium channel, or ENaC. Both proteins ... exactly what role each plays is unclear. ...
Cached Biology News:Cystic fibrosis proteins photographed interacting 2
Handy 100V Power Supply is Low-cost, compact and lightweight. Easy to operate - either 50 or 100 VDC is selectable as the output voltage. These voltages are sufficient for ordinary electrophoresis....
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
...
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
Biology Products: